Novel therapies for pancreatic cancer: setbacks and progress.
Wong
Han Hsi
HH
Lemoine
Nicholas R
NR
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016503:Drug Delivery Systems / Q000639:trends*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D015398:Signal Transduction; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine